Refresh
Company Event • 31 Jan 2022 15:15 • Latest
Location:Japan
3rd Quarter of FY2021 Financial Results Announcement
Speakers
- Toru Kimura (Representative Director, Executive Vice President, CSO, Sumitomo Dainippon Pharma Co., Ltd.)
- Hisayoshi Kashima (Senior Director, Finance & Accounting, Sumitomo Dainippon Pharma Co., Ltd.)
Analysts
- Tomohiro Tanaka (Analyst, SMBC Nikko Securities Inc.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Seiji Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
- Stephen Barker (Analyst, Jefferies Japan Limited)
- Naoya Miura (Analyst, Jefferies Japan Limited)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Hiroshi Tanaka (Analyst, Mizuho Securities Co., Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Motoya Kohtani (Analyst, Nomura Securities Co., Ltd.)
Company Event • 08 Sep 2021 12:00
Location:Japan
Frontier Business Meeting- FBO Showcase -
Speakers
- Hiroshi Nomura (Representative Director, President and CEO, Sumitomo Dainippon Pharma Co., Ltd.)
- Toru Kimura (Representative Director, Executive Vice President, Chief Scientific Officer, Sumitomo Dainippon Pharma Co., Ltd.)
- Hiroyuki Baba (Senior Executive Officer, Sumitomo Dainippon Pharma Co., Ltd.)
- Takehiko Nomura (Senior Director, Frontier Business Office, Sumitomo Dainippon Pharma Co., Ltd.)
- Seiji Hori (Officer, Business Development & Portfolio Strategy, Frontier Business Office, Sumitomo Dainippon Pharma Co., Ltd.)
- Tetsuya Uyama (Officer, Frontier Business Office, Sumitomo Dainippon Pharma Co., Ltd.)
- Yukako Nishimaki (Business Promotion Officer, Frontier Business Office, Sumitomo Dainippon Pharma Co., Ltd.)
- Yasushi Ochiai (Planning and Development Officer, Frontier Business Office, Sumitomo Dainippon Pharma Co., Ltd.)
- Miwako Harada (Senior Director, Corporate Communications, Sumitomo Dainippon Pharma Co., Ltd.)
- Junichi Kato (COO, Aikomi Ltd.)
- Masahiro Kasuya (CEO, MELTIN MMI)
- Aaron Gani (CEO, BehaVR, Inc.)
- Peter Buecker (Chief Medical Officer, BehaVR, Inc.)
- Haley Eberly (Head of Product Management, BehaVR, Inc.)
Analysts
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
Company Event • 29 Jul 2021 14:30
Location:Japan
1st Quarter of FY2021 financial results announcement
Speakers
- Hiroshi Nomura (Representative Director, President and CEO, Sumitomo Dainippon Pharma Co., Ltd.)
- Toru Kimura (Representative Director, Executive Vice President, Chief Scientific Officer, Sumitomo Dainippon Pharma Co., Ltd.)
- Hisayoshi Kashima (Senior Director, Finance & Accounting, Sumitomo Dainippon Pharma Co., Ltd.)
Analysts
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Stephen Barker (Analyst, Jefferies Japan Limited)
Duration
- Presentation: 31 minutes
- Q&A: 31 minutes
Company Event • 13 May 2021 14:30
Location:Japan
Investors Meeting Presentation for FY2020 (Year ended March 31, 2021) and Revision of Mid-term Business Plan 2022
Speakers
- Hiroshi Nomura (Representative Director, President and CEO, Sumitomo Dainippon Pharma Co., Ltd.)
- Toru Kimura (Representative Director, Executive Vice President, Chief Scientific Officer, Sumitomo Dainippon Pharma Co., Ltd.)
Analysts
- Shohei Oda (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)
- Stephen Barker (Analyst, Jefferies Japan Limited)
- Fumiyoshi Sakai (Analyst, Credit Suisse Securities (Japan) Limited)
- Wakao (Analyst, JPMorgan Securities Japan Co., Ltd.)
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
- Hidemaru Yamaguchi (Analyst, Citigroup Global Markets Japan Inc.)
Duration
- Presentation: 42 minutes
- Q&A: 42 minutes
Company Event • 29 Jan 2021 14:30
Location:Japan
3nd Quarter of FY2020 Financial Results Announcement
Speakers
- Hiroshi Nomura (Representative Director, President and CEO, Sumitomo Dainippon Pharma Co., Ltd.)
- Hisayoshi Kashima (Senior Director, Finance & Accounting, Sumitomo Dainippon Pharma Co., Ltd.)
Analysts
- Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)